Cargando…

Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study

BACKGROUND/AIMS: Recently neoadjuvant chemotherapy (NAC) for pancreatic cancer has been shown to be superior to upfront surgery, but it remains a matter of debate for resectable cases. In clinical practice, some resectable cases may become unresectable after NAC. This study aimed to reveal the outco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murakami, Masatoshi, Fujimori, Nao, Ohno, Akihisa, Matsumoto, Kazuhide, Teramatsu, Katsuhito, Takamatsu, Yu, Takeno, Ayumu, Oono, Takamasa, Abe, Toshiya, Ideno, Noboru, Ikenaga, Naoki, Nakata, Kohei, Nakamura, Masafumi, Ishigami, Kousei, Ogawa, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777497/ https://www.ncbi.nlm.nih.gov/pubmed/35201490 http://dx.doi.org/10.1007/s12672-021-00462-1

Ejemplares similares

Circulating CD8(+)CD122(+) T cells as a prognostic indicator of pancreatic cancer
por: Teramatsu, Katsuhito, et al.
Publicado: (2022)

The Glasgow Prognostic Score and stricture site can predict prognosis after endoscopic duodenal stent placement for malignant gastric outlet obstruction
por: Takamatsu, Yu, et al.
Publicado: (2022)

Clinical significance of postpancreatectomy acute pancreatitis defined by the International Study Group for Pancreatic Surgery
por: Ikenaga, Naoki, et al.
Publicado: (2022)

Efficacy of Early Endoscopic Ultrasound-Guided Transluminal Drainage for Postoperative Pancreatic Fistula
por: Fujimori, Nao, et al.
Publicado: (2021)

Endoscopic tamponade using a fully covered self-expandable metallic stent for massive biliary bleeding from a pseudoaneurysm rupture during metallic stent removal
por: Fujimori, Nao, et al.
Publicado: (2020)

Usefulness of a gel immersion-assisted EUS-guided fine-needle aspiration/biopsy for ampullary lesions (with videos)
por: Minoda, Yosuke, et al.
Publicado: (2021)

2207: A Phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer
por: Ezra Shabason, Jacob, et al.
Publicado: (2018)

Rescue technique for bleeding after placement of plastic stent in EUS–guided hepaticogastrostomy (with videos)
por: Ohno, Akihisa, et al.
Publicado: (2023)

The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center
por: Ohno, Akihisa, et al.
Publicado: (2022)

Administration Method of Adjuvant Tegafur‐Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study
por: Hata, Taishi, et al.
Publicado: (2021)

Bile peritonitis after placement of a metallic stent in endoscopic ultrasound-guided hepaticogastrostomy: A pitfall and the rescue technique
por: Ohno, Akihisa, et al.
Publicado: (2022)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
por: Janssen, Quisette P., et al.
Publicado: (2020)

Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
por: Massani, Marco, et al.
Publicado: (2023)

In‐hospital cost analysis of prostatic artery embolization compared with transurethral resection of the prostate: post hoc analysis of a randomized controlled trial
por: Müllhaupt, Gautier, et al.
Publicado: (2019)

Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
por: Versteijne, Eva, et al.
Publicado: (2022)

Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer
por: Imamura, Masafumi, et al.
Publicado: (2021)

Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
por: Mikulic, Danko, et al.
Publicado: (2021)

Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study
por: Miki, Masami, et al.
Publicado: (2022)

Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
por: Katsurada, Naoko, et al.
Publicado: (2020)

CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors
por: Miki, Masami, et al.
Publicado: (2019)

Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
por: Nichols, Romaine Charles, et al.
Publicado: (2019)

Borderline resectable pancreatic cancer: Certainties and controversies
por: Nappo, Gennaro, et al.
Publicado: (2021)

Treatment of anastomotic leakage after rectal cancer resection: The TENTACLE–Rectum study
por: van Workum, Frans, et al.
Publicado: (2020)

Balloon guidewire technique during EUS-guided hepaticogastrostomy
por: Ohno, Akihisa, et al.
Publicado: (2021)

Spy basket retrieval method of an embedded hepaticogastrostomy stent (with videos)
por: Ohno, Akihisa, et al.
Publicado: (2022)

Endoscopic mucosal resection-precutting vs conventional endoscopic mucosal resection for sessile colorectal polyps sized 10-20 mm
por: Zhang, Xue-Qun, et al.
Publicado: (2022)

Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
por: Trinh, Katherine V., et al.
Publicado: (2020)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Bonds, Morgan, et al.
Publicado: (2019)

Cutting‐edge strategies for borderline resectable pancreatic cancer
por: Shinde, Rajesh S., et al.
Publicado: (2019)

Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management
por: Fawaz, Ali, et al.
Publicado: (2022)

Laparoscopic pancreatectomies for borderline tumors with major venous resections
por: Borys, Maciej, et al.
Publicado: (2022)

Randomized clinical trial of prophylactic transanal irrigation versus supportive therapy to prevent symptoms of low anterior resection syndrome after rectal resection
por: Rosen, H. R., et al.
Publicado: (2019)

Editorial: Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Conference
por: Berlin, Jordan, et al.
Publicado: (2009)

Survival outcome and prognostic factors of neoadjuvant treatment followed by resection for borderline resectable pancreatic cancer
por: Kim, Hyeong Seok, et al.
Publicado: (2017)

The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
por: Sakaguchi, Tatsuma, et al.
Publicado: (2020)

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
por: Iyengar, Siddharth, et al.
Publicado: (2021)

Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
por: Vernuccio, Federica, et al.
Publicado: (2021)

Meta‐analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
por: Versteijne, E., et al.
Publicado: (2018)

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Cloyd, Jordan M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fkklgju3bjldvorueh55m5q15v